Aberrant gene promoter methylation marking disease progression in multiple myeloma

Leukemia. 2006 Jun;20(6):1190-2. doi: 10.1038/sj.leu.2404205.
No abstract available

Publication types

  • Case Reports
  • Comparative Study
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • DNA Methylation*
  • Disease Progression
  • Fatal Outcome
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / diagnosis
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / genetics*
  • Promoter Regions, Genetic / genetics*